Examining Interactions Between Persons with ALS and Caregivers

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS when they interact with their caregivers and does this change over time? Participants will read words and sentences while they are interacting with their caregivers.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: t
View:

⁃ Speakers with amyotrophic lateral sclerosis (ALS) (PALS-people with ALS)

• diagnosis of ALS following the revised EL Escorial criteria

• no history of other neurological conditions (e.g., stroke)

• no cognitive impairment assessed by Telephone Montreal Cognitive Assessment (mini MoCA)

• detectable speech disturbance according to the ALS Functional Rating Scale-Revised (ALSFRS-R)

• the ability to produce single words

• being a native speaker of American English (AE).

⁃ Caregivers

• being a caregiver of a participant with ALS

• being a native speaker of American English (AE).

Locations
United States
Pennsylvania
Speech Core, Pennsylvania State University
RECRUITING
University Park
Contact Information
Primary
Anne Olmstead, Ph.D.
ajo150@psu.edu
814-867-3373
Backup
Navin Viswanathan, Ph.D
nxv175@psu.edu
814-867-2340
Time Frame
Start Date: 2025-01-22
Estimated Completion Date: 2029-02-28
Participants
Target number of participants: 152
Treatments
Experimental: People with ALS and their caregivers
People with ALS and their caregivers will participate in structured communicative interaction.
Sponsors
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
Leads: Penn State University

This content was sourced from clinicaltrials.gov